Cipla USA, Inc. Cinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle recall: CGMP Deviations: the presence of a nitrosamine impurity
CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.
The hazard: Harmful chemical exposure
This notice concerns a chemical found in the product at a level regulators consider unsafe, which is usually caught by laboratory testing rather than by anybody noticing a problem.
What the notice says: CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.
Why it matters: A chemical that should not be present at this level was found in the product. Depending on the substance, the concern may be a burn or irritation on contact, or a long-term risk from repeated exposure.
Symptoms and when to call a doctor
For a splash or spill, rinse the skin or eyes with running water for 15 to 20 minutes and remove contaminated clothing. If the product was swallowed, or if there is any trouble breathing, call Poison Control on 1-800-222-1222, which operates free and around the clock — or 911 if the person is collapsing, struggling to breathe or unconscious. Take the container or a photo of the label with you to any appointment.
This page is general information, not medical advice. If you feel unwell, a clinician who can see you is the only person able to judge your case.
Recall details
- Recall number
- D-0224-2026
- Published
- December 17, 2025
- Risk level
- Class II
- Status
- Ongoing
- Issued by
- U.S. Food and Drug Administration
- Brand
- Cipla USA, Inc.
- Product type
- Prescription & OTC drugs
- Units affected
- 63,504 bottles
- Distribution
- Nationwide
- Made in
- United States
- Lot / code info
- Lot, expiry: Lot 4PB0109, exp 1/31/2026; Lot 5PB0172, exp 1/31/2027
Products covered by this recall
Cinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle, Rx Only, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-410-02
Check your product
The notice names 15 codes you can read straight off the package. Type the one printed on yours and the list below narrows to it.
Lot or batch code
Usually ink-stamped near the seam, the cap or the bottom of the pack.
- 4PB0109
- exp 1
- 31
- 2026
- 5PB0172
- 2027 — 63
- 504 bottles
Best-by / use-by date
Printed beside the lot code, not on the price sticker.
- Lot 4PB0109
- exp 1
- 31
- 2026
- 2027 — 63
- 504 bottles
NDC number
On the carton and again on the bottle or blister label.
- 69097-410-02
Package size
Match the net weight or the piece count on the front of the pack.
- 30 mg
Codes are lifted verbatim from the FDA — Drug enforcement notice. A code that is missing here may still be covered — the official notice is the complete list.
What to do about Chemical
Cipla USA, Inc. — This notice concerns a chemical found in the product at a level regulators consider unsafe, which is usually caught by laboratory testing rather than by anybody noticing a problem.
- Stop using the product and keep it away from children and pets.
- Ventilate the room if the product was sprayed or applied there.
- Keep the container — the lot code on it is what a refund claim and any medical follow-up both depend on.
- If anyone has symptoms, call Poison Control on 1-800-222-1222 rather than guessing.
How the remedy works
CPSC recalls specify one of three remedies, and which one you get is not negotiable — but how smoothly it goes often is.
- A refund means the purchase price back, sometimes prorated by age for durable goods. Ask how they calculated it if the figure looks low.
- A repair kit is shipped free and is designed to be fitted at home; if you cannot fit it, ask whether they will arrange installation.
- A replacement is usually the current model, not the recalled one. Confirm the replacement is not itself under recall.
- Several recalls now ask you to destroy the item and send a photo as proof. Register the claim before you do that, never after.
Company contact: Cipla USA, Inc. — 10 Independence Blvd, Warren, NJ, 07059-2730
The official notice
This page summarises a notice published by U.S. Food and Drug Administration. The agency notice is the authoritative version — read it before you act, and treat it as the final word if anything here looks different.
Open the FDA — Drug enforcement record U.S. Food and Drug Administration recalls
Questions people ask about this recall
Why was Cipla USA, Inc. prescription & otc drugs recalled?
CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits. CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.
How do I know if I have the recalled product?
Match the codes printed on your package against the notice: lot code 4PB0109, exp 1, 31; best-by date Lot 4PB0109 or exp 1. If the code on your package is not on that list, your unit is outside the recall.
What should I do with it right now?
Stop using the product and keep it away from children and pets.
Can I get my money back?
A refund means the purchase price back, sometimes prorated by age for durable goods. Ask how they calculated it if the figure looks low.
Where was the recalled product sold?
It was distributed nationwide.
Related recalls
-
Class II · 11 days ago
Cipla USA, Inc. Fosfomycin Tromethamine Granules for Oral Solution recall: Failed Impurities/Degradation Specifications
Failed Impurities/Degradation Specifications
-
Class II · 4 months ago
Cipla USA, Inc. Cinacalcet Hydrochloride Tablets, 30 mg, 30-count bottle recall: cGMP Deviations: presence of N-nitroso-cinacalcet
cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).
-
Class II · 4 months ago
Cipla USA, Inc. Cinacalcet Hydrochloride Tablets, 90 mg, 30-count bottle recall: cGMP Deviations: presence of N-nitroso-cinacalcet
cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).
-
Class II · 4 months ago
Cipla USA, Inc. Cinacalcet Hydrochloride Tablets, 60 mg, 30-count bottle recall: cGMP Deviations: presence of N-nitroso-cinacalcet
cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).
-
Class II · 6 months ago
Cipla USA, Inc. Cinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle recall: CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily
CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit
-
Class II · 6 months ago
Cipla USA, Inc. Cinacalcet Hydrochloride Tablets, 90 mg, 30 Tablets per bottle recall: CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily
CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit